Long-Term MR Imaging Course of Neurodegenerative Langerhans Cell Histiocytosis
Open Access
- 1 June 2007
- journal article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 28 (6) , 1022-1028
- https://doi.org/10.3174/ajnr.a0509
Abstract
BACKGROUND AND PURPOSE: MR imaging signal intensity abnormalities in the cerebellum, the pons, and the basal ganglia, compatible with a neurodegenerative process (ND) were reported in up to 10% of patients with Langerhans cell histiocytosis (LCH). Although the imaging features of ND-LCH have been extensively described, the temporal course of ND-LCH has not been assessed as of yet. The purpose of this study was to describe the long-term course of MR imaging signal intensity abnormalities in ND-LCH on T1- and T2-weighted images. MATERIALS AND METHODS: In this retrospective study, 9 patients with ND-LCH with an observation time of at least 5 years were included. Three or more MR imaging studies per patient, performed in 3-year intervals (±11 months), were reviewed. Signal intensity abnormalities on T1- and T2-weighted images in the cerebellum, the pons, and basal ganglia were scored for their signal intensity quality and their extension. In addition, the severity of cerebellar atrophy was scored. RESULTS: The signal intensity alterations were not resolved in any of the patients. Instead, a progression of the signal intensity alterations either in the cerebellum or basal ganglia was observed in all of the patients but did not correlate with a clinical deterioration. Overt and severe neurologic symptoms were reported in only 2 patients in whom some form of atrophy was noted. CONCLUSIONS: ND-LCH appears to be a slowly progressive process. The increase of signal intensity abnormalities in the cerebellum and basal ganglia does not correlate with neurologic deterioration. MR imaging appears to be a sensitive technique to detect and monitor radiologic ND-LCH.Keywords
This publication has 22 references indexed in Scilit:
- Central nervous system‐related permanent consequences in patients with Langerhans cell histiocytosisPediatric Blood & Cancer, 2006
- Risk factors for diabetes insipidus in langerhans cell histiocytosisPediatric Blood & Cancer, 2005
- Neuropathology of CNS disease in Langerhans cell histiocytosisBrain, 2005
- Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosisPediatric Blood & Cancer, 2004
- Endocrine involvement in pediatric-onset langerhans' cell histiocytosis: a population-based studyThe Journal of Pediatrics, 2004
- Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society—Late Effects Study GroupPediatric Blood & Cancer, 2004
- Acute ataxia complicating Langherans cell histiocytosisArchives of Disease in Childhood, 2002
- A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.Archives of Disease in Childhood, 1996
- Progressive spinocerebellar degeneration "plus" associated with Langerhans cell histiocytosis: a new paraneoplastic syndrome?Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Treatment strategy for disseminated langerhans cell histiocytosisMedical and Pediatric Oncology, 1994